Hope on the Horizon: Trials, Treatments and Therapies for DMD, DM1 & MG
Muscular Dystrophy Canada in partnership with the Neuromuscular Disease Network for Canada’s Clinical Trial Network is excited to host three Hope on the Horizon events!
These webinars are geared towards family members and people living with NMDs.
Join us to learn more about the treatment and clinical trial landscape for Duchenne Muscular Dystrophy, Myotonic Dystrophy Type 1 and Myasthenia Gravis from key experts in the field!
Learn More and Register:
- Nov 26, 2025: Duchenne Muscular Dystrophy
- Nov 27, 2025: Myotonic Dystrophy Type 1
- Nov 28, 2025: Myasthenia Gravis
Post-Event Update
Click to watch the webinars on MDC’s YouTube Channel.
Read next...
New Milestone: 100 Canadian Neuromuscular Clinical Trials now listed in our database!
We are happy to announce that our Neuromuscular Clinical Trial Database, developed in partnership with Muscular Dystrophy Canada, has officially reached 100 Canadian clinical trial listings!
New Standard Operating Procedure: Measurement and Analysis of Mitochondrial Function In Situ in Permeabilized Muscle Fibers
We are excited to announce the release of our latest Standard Operating Procedure (SOP) titled “Measurement and Analysis of Mitochondrial Function In Situ in Permeabilized Muscle Fibers”, developed by our BSTC members Dr. Sean Ng and Magda Lensinski.
NMD4C Hosts 2nd Annual Clinical Summer School at the University of Calgary!
On 24 September 2026, our second annual NMD4C Clinical Summer School brought together 25 neuromuscular fellows from across Canada to the University of Calgary for a day of hands-on learning, discussion, connection, and collaboration.